Day: January 24, 2022

ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg offentliggør forventede udbytter for 2021 for afdelinger og andelsklasser i Investeringsforeningen Sparinvest. Udbytterne er foreløbige og ureviderede. Det skal derfor fremhæves, at de endelige udbytter kan ændre sig i forhold til de forventede udbytter. De forventede udbytter forventes at blive udbetalt til investorernes konti fredag den 25. februar 2022. Den sidste handelsdag med investeringsbeviser inkl. de forventede udbytter indeholdt i indre værdi er den 22. februar 2022. Den første handelsdag med investeringsbeviser ekskl. forventede udbytter indeholdt i indre værdi er den 23. februar 2022.  De endelige udbytter vil blive offentliggjort inden udbetalingen. Der gøres opmærksom på, at de endelige udbytter skal godkendes på foreningens generalforsamling. De forventede, optjente udbytter...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN UNITED STATES, CANADA, AUSTRALIA, NEW ZEALAND, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Mowi ASA announces intention to launch voluntary offer for NTS ASA at NOK 110 per share 24 January 2022 – Mowi ASA is pleased to announce that it intends to launch an offer to acquire all of the shares of NTS ASA at NOK 110 per share, to be settled 50 % in cash and 50 % in shares issued in Mowi. Mowi has followed the NTS Group for several years and is impressed by how the employees, management team and owners have developed the NTS Group into one of the leading producers of Atlantic salmon in Norway and Iceland. From a strong foundation in Central Norway, the NTS Group has grown into a fully integrated...

Agreement to divest the FPSO BW Joko Tole BW Offshore has today signed an agreement for the sale of the FPSO BW Joko Tole to PT Bahari Inti Tanker and PT Cahaya Haluan Pasifik, both of which are Indonesian companies, in consortium with PT Buana Lintas Lautan Tbk, a company publicly listed in Indonesia. The consortium will continue to operate the FPSO under the lease contract with Kangean Energy Indonesia. The transaction is part of BW Offshore’s strategy to transition to floating energy infrastructure investments. The sale will free up over USD 50 million of liquidity, comprising of net sale proceeds of USD 42.5 million and the release of USD 9 million of working capital upon closing. There is no debt attached to the FPSO. The Company expects to book a loss from the transaction of around USD 23 million and a tax expense of approximately...

Top-line Data Expected in the Third Quarter of 2022 LONDON and RALEIGH, N.C., Jan. 24, 2022 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, today announces it has completed patient enrollment with more than 800 subjects randomized in the ENHANCE-2 trial, evaluating ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease (“COPD”). Top-line data are expected in the third quarter of 2022. “Completing enrollment in the Phase 3 ENHANCE-2 trial with more than 800 subjects is an important accomplishment for Verona Pharma,” said David Zaccardelli, Pharm. D., President and Chief Executive Officer. “We are pleased to achieve our recruitment targets during the ongoing global pandemic.” “We expect...